<--- Back to Details
First PageDocument Content
Medicine / Ovarian hyperstimulation / Gonadotropin-releasing hormone antagonist / In vitro fertilisation / Human chorionic gonadotropin / Gonadotropin-releasing hormone agonist / Transvaginal oocyte retrieval / Polycystic ovary syndrome / Anovulation / Human reproduction / Fertility medicine / Biology
Date: 2014-12-17 05:38:44
Medicine
Ovarian hyperstimulation
Gonadotropin-releasing hormone antagonist
In vitro fertilisation
Human chorionic gonadotropin
Gonadotropin-releasing hormone agonist
Transvaginal oocyte retrieval
Polycystic ovary syndrome
Anovulation
Human reproduction
Fertility medicine
Biology

Microsoft Word - Oct[removed]updated report on OHSS for the HFEA by Adam Balen.doc

Add to Reading List

Source URL: www.hfea.gov.uk

Download Document from Source Website

File Size: 88,42 KB

Share Document on Facebook

Similar Documents

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1  1.

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1.

DocID: 16voX - View Document

IVF/GIFT Elonva® applications  Purpose of this form Filling in this form

IVF/GIFT Elonva® applications Purpose of this form Filling in this form

DocID: UsX0 - View Document

SOGC CLINICAL PRACTICE GUIDELINE No. 315, November 2014 The Prevention of Ovarian Hyperstimulation Syndrome This clinical practice guideline has been prepared by the

SOGC CLINICAL PRACTICE GUIDELINE No. 315, November 2014 The Prevention of Ovarian Hyperstimulation Syndrome This clinical practice guideline has been prepared by the

DocID: JtWT - View Document

SOGC CLINICAL PRACTICE GUIDELINE No. 315, November 2014 The Prevention of Ovarian Hyperstimulation Syndrome This clinical practice guideline has been prepared by the

SOGC CLINICAL PRACTICE GUIDELINE No. 315, November 2014 The Prevention of Ovarian Hyperstimulation Syndrome This clinical practice guideline has been prepared by the

DocID: ISkM - View Document

SOGC CLINICAL PRACTICE GUIDELINE No. 315, November 2014 The Prevention of Ovarian Hyperstimulation Syndrome This clinical practice guideline has been prepared by the

SOGC CLINICAL PRACTICE GUIDELINE No. 315, November 2014 The Prevention of Ovarian Hyperstimulation Syndrome This clinical practice guideline has been prepared by the

DocID: IJbr - View Document